Navigation Links
LS9, Inc., the Renewable Petroleum Company(TM), Adds Key Positions to Executive Team and Scientific Advisory Board

Wei Huang named Vice President of Process Development and Engineering

Christopher Stone named Vice President of Legal Affairs

Drs. John Cronan and Uwe Sauer Join Scientific Advisory Board

SAN CARLOS, Calif., Feb. 6 /PRNewswire/ -- LS9, Inc., the Renewable Petroleum Company(TM), today announced the addition of two key members of its executive team: Wei Huang has been named the company's Vice President of Process Development and Engineering, and Christopher Stone has been named the company's Vice President of Legal Affairs.

Wei Huang, who was previously Director of Process Engineering at Fluor Corporation, one of the world's largest, publicly-owned engineering companies, will oversee the company's process engineering and scale-up of DesignerBiofuels(TM) products. Ms. Huang brings more than 17 years of experience in process development, scale up and product commercialization for the biotechnology and chemical industries. Her expertise in facility and equipment design and operations support will be critical in the company's production and commercialization of advanced biofuels.

Also, to ensure the company's strong leadership in intellectual property, patents, and strategic partnerships, Christopher Stone has joined the LS9 management team to oversee the company's legal affairs. Mr. Stone brings 17 years of legal, intellectual property, and transaction experience, including 12 years working in the industrial biotechnology sector. Prior to joining LS9, Mr. Stone held the roles of Vice President, Intellectual Assets at Danisco A/S and Vice President, General Patent Counsel at Genencor International, Inc. Mr. Stone's responsibilities at the company will include intellectual property protection and management, contract negotiation and drafting, participation in business operations and strategic planning, and litigation management.

"We are truly fortunate to be joined by both Wei Huang and Chris Stone as we've moved into commercialization," said Robert Walsh, President of LS9. "Both combine exceptional talent with years of experience bringing new products to market, and will extend our leadership position for hydrocarbon biofuels," he said.

In addition, LS9 has expanded its scientific advisory board to further development of Renewable Petroleum(TM) technology with the addition of distinguished scientists Dr. John Cronan and Dr. Uwe Sauer. Dr. Cronan is Alumni Professor of Microbiology and Professor of Biochemistry at the University of Illinois, Urbana-Champaign, and also serves as Head of the Department of Microbiology. He pioneered genetic approaches to understanding the mechanisms and regulation of bacterial lipid metabolism and is a leading expert on fatty acid biosynthesis. Dr. Uwe Sauer is Professor of Systems Biology in the Department of Biology at the Swiss Federal Institute of Technology in Zurich. He is a well-recognized expert on central metabolism of bacteria and yeast.

About LS9

LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held biotechnology company and the pioneer in the commercial development of hydrocarbon biofuels. LS9 is pursuing industrial applications of synthetic biology to produce proprietary hydrocarbon biofuels that are compatible with existing fuel distribution and consumer infrastructure. LS9's patent-pending DesignerBiofuels(TM) products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. The venture capital firms Flagship Ventures, Khosla Ventures and Lightspeed Venture Partners have provided funding to date. LS9 is headquartered in San Carlos, California, in the heart of Silicon Valley.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
2. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
5. BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
6. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
7. ADVENTRX Announces Consolidation of Clinical and Management Positions
8. Monsanto Executives to Address Investor Conferences in February
9. BioSeek Elects Roy Whitfield Executive Chairman of Board of Directors
10. China Pharma Appoints Three Independent Non-Executive Directors
11. Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer
Post Your Comments:
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
Breaking Biology News(10 mins):